However, lower CEACAM1 expression levels were observed in higher tumor size status, metastasis status, pathologic stage, histologic grade, unfavourable patient survival status, and male patients (Figures 1(d)–1(k)). The gene discussed is CEACAM1; the disease is neoplasm.